(Q38366498)

English

Dopamine and T cells: dopamine receptors and potent effects on T cells, dopamine production in T cells, and abnormalities in the dopaminergic system in T cells in autoimmune, neurological and psychiatric diseases

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 September 2017

1 reference

Europe PubMed Central

Dopamine and T cells: dopamine receptors and potent effects on T cells, dopamine production in T cells, and abnormalities in the dopaminergic system in T cells in autoimmune, neurological and psychiatric diseases (English)

1 reference

Europe PubMed Central

2 September 2017

0 references

author name string

M Levite

1

1 reference

Europe PubMed Central

2 September 2017

publication date

26 February 2015

1 reference

Europe PubMed Central

2 September 2017

Acta Physiologica

1 reference

Europe PubMed Central

2 September 2017

216

1 reference

Europe PubMed Central

2 September 2017

1

1 reference

Europe PubMed Central

2 September 2017

42-89

1 reference

Europe PubMed Central

2 September 2017

Dopaminergic therapies modulate the T-CELL proteome of patients with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Recent advances in Tourette syndrome research

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Impaired response to amphetamine and neuronal degeneration in the nucleus accumbens of autoimmune MRL-lpr mice.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Autoimmune-induced damage of the midbrain dopaminergic system in lupus-prone mice

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Increased expression of dopamine receptors on lymphocytes in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Dopaminergic symptoms in migraine

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Lymphocyte populations in Parkinson's disease and in rat models of parkinsonism

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Dopamine, a neurotransmitter, influences the immune system

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

D1 and D2 dopamine receptor-mediated inhibition of activated normal T cell proliferation is lost in jurkat T leukemic cells

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

The physiology, signaling, and pharmacology of dopamine receptors

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Nitrated alpha-synuclein immunity accelerates degeneration of nigral dopaminergic neurons

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Discovery of endogenous catecholamines in lymphocytes and evidence for catecholamine regulation of lymphocyte function via an autocrine loop

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Measurements of catecholamine-mediated apoptosis of immunocompetent cells by capillary electrophoresis.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Dopamine by itself activates either D2, D3 or D1/D5 dopaminergic receptors in normal human T-cells and triggers the selective secretion of either IL-10, TNFalpha or both.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Calcium homeostasis is dysregulated in parkinsonian patients with L-DOPA-induced dyskinesias.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

D3 dopamine receptor mRNA is elevated in T cells of schizophrenic patients whereas D4 dopamine receptor mRNA is reduced in CD4+ -T cells

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Increase in dopaminergic, but not serotoninergic, receptors in T-cells as a marker for schizophrenia severity.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Catecholamine-producing cells in the synovial tissue during arthritis: modulation of sympathetic neurotransmitters as new therapeutic target

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

In vivo administration of L-dopa or dopamine decreases the number of splenic IFN gamma-producing cells

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

A prospective longitudinal study of Gilles de la Tourette's syndrome.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Adrenergic and dopaminergic modulation of immunity in multiple sclerosis: teaching old drugs new tricks?

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Stimulation with phytohaemagglutinin induces the synthesis of catecholamines in human peripheral blood mononuclear cells: role of protein kinase C and contribution of intracellular calcium

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Catecholamine production and tyrosine hydroxylase expression in peripheral blood mononuclear cells from multiple sclerosis patients: effect of cell stimulation and possible relevance for activation-induced apoptosis

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Dopaminergic modulation of oxidative stress and apoptosis in human peripheral blood lymphocytes: evidence for a D1-like receptor-dependent protective effect.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Human CD4+CD25+ regulatory T cells selectively express tyrosine hydroxylase and contain endogenous catecholamines subserving an autocrine/paracrine inhibitory functional loop.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Expression of apoptosis-related proteins and of mRNA for dopaminergic receptors in peripheral blood mononuclear cells from patients with Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Dopamine and noradrenaline control distinct functions in rodent microglial cells.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Dopaminergic D1-like receptor-dependent inhibition of tyrosine hydroxylase mRNA expression and catecholamine production in human lymphocytes.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Dopaminergic receptor D5 mRNA expression is increased in circulating lymphocytes of Tourette syndrome patients

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Dopamine favors expansion of glucocorticoid-resistant IL-17-producing T cells in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Does Parkinson's disease have an immunological basis? The evidence and its therapeutic implications

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Predicting haloperidol occupancy of central dopamine D2 receptors from plasma levels.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Upregulation of phagocyte-derived catecholamines augments the acute inflammatory response

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Human T cells express a functional ionotropic glutamate receptor GluR3, and glutamate by itself triggers integrin-mediated adhesion to laminin and fibronectin and chemotactic migration

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Human immunodeficiency virus (HIV) infection of human macrophages is increased by dopamine: a bridge between HIV-associated neurologic disorders and drug abuse

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Dopamine inhibits cytokine release and expression of tyrosine kinases, Lck and Fyn in activated T cells.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Dopamine fails to regulate activation of peripheral blood lymphocytes from multiple sclerosis patients: effects of IFN-beta

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Dopamine receptor D3 expressed on CD4+ T cells favors neurodegeneration of dopaminergic neurons during Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

A detailed anatomical analysis of neurotransmitter receptors in the putamen and caudate in Parkinson's disease and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Increase in peripheral CD4 bright+ CD8 dull+ T cells in Parkinson disease.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

A peripheral marker for schizophrenia: Increased levels of D3 dopamine receptor mRNA in blood lymphocytes

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Distorted expression of dopamine receptor genes in systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Anti-inflammatory effects of cell-based therapy with tyrosine hydroxylase-positive catecholaminergic cells in experimental arthritis

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Catecholamines are synthesized by mouse lymphocytes and regulate function of these cells by induction of apoptosis

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Dopamine D2 receptors in the hippocampus and amygdala in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Dopamine D2 receptor bands in normal human temporal cortex are absent in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Dopamine, through the extracellular signal-regulated kinase pathway, downregulates CD4+CD25+ regulatory T-cell activity: implications for neurodegeneration.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Dopamine receptors in human lymphocytes: radioligand binding and quantitative RT-PCR assays

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Reduction of rat brain CD8+ T-cells by levodopa/benserazide treatment after experimental stroke

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

The inflammatory reaction following 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine intoxication in mouse.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

The behavioral spectrum of tic disorders: a community-based study.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Expression of dopaminergic receptors on human CD4+ T lymphocytes: flow cytometric analysis of naive and memory subsets and relevance for the neuroimmunology of neurodegenerative disease.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Change of dopamine receptor mRNA expression in lymphocyte of schizophrenic patients

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Neuropeptides, by direct interaction with T cells, induce cytokine secretion and break the commitment to a distinct T helper phenotype

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Neurotransmitters activate T-cells and elicit crucial functions via neurotransmitter receptors

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Dopamine interacts directly with its D3 and D2 receptors on normal human T cells, and activates beta1 integrin function

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Loss of dopamine receptors in the olfactory bulb of patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Decreased availability of intestinal dopamine in transmural colitis may relate to inhibitory effects of interferon-gamma upon L-DOPA uptake.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Dopamine D2 receptor polymorphisms in inflammatory bowel disease and the refractory response to treatment.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Microglial responses to dopamine in a cell culture model of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Dopamine receptor expression on human T- and B-lymphocytes, monocytes, neutrophils, eosinophils and NK cells: a flow cytometric study

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Bromocriptine in rheumatic and autoimmune diseases

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Increased prefrontal D2 protein in Tourette syndrome: a postmortem analysis of frontal cortex and striatum

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

D1-like dopamine receptors antagonist inhibits cutaneous immune reactions mediated by Th2 and mast cells

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Damage to dopamine systems differs between Parkinson's disease and Alzheimer's disease with parkinsonism.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Decrease of the D3 dopamine receptor mRNA expression in lymphocytes from patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Antagonizing dopamine D1-like receptor inhibits Th17 cell differentiation: preventive and therapeutic effects on experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Dopamine released by dendritic cells polarizes Th2 differentiation

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Dopamine as an immune-modulator between dendritic cells and T cells and the role of dopamine in the pathogenesis of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Dopamine induces IL-6-dependent IL-17 production via D1-like receptor on CD4 naive T cells and D1-like receptor antagonist SCH-23390 inhibits cartilage destruction in a human rheumatoid arthritis/SCID mouse chimera model.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Therapeutic effect of D1-like dopamine receptor antagonist on collagen-induced arthritis of mice

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

A possible role for humoral immunity in the pathogenesis of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Role of dopamine in the physiology of T-cells and dendritic cells

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

The dopaminergic system in autoimmune diseases

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Bromocriptine restores tolerance in estrogen-treated mice

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Reduced striatal dopamine receptors in Alzheimer's disease: single photon emission tomography study with the D2 tracer [123I]-IBZM.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Stimulation of dopamine receptor D5 expressed on dendritic cells potentiates Th17-mediated immunity

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Modulation of T-cell mediated immunity by dopamine receptor d5

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Increased dopamine content in lymphocytes from high-dose L-Dopa-treated Parkinson's disease patients

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Nitrated {alpha}-synuclein-induced alterations in microglial immunity are regulated by CD4+ T cell subsets

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Dopamine D5 receptors in human peripheral blood lymphocytes: a radioligand binding study

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Expression of dopamine receptors in immune organs and circulating immune cells

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Pharmacological characterization and autoradiographic localization of a putative dopamine D4 receptor in the heart

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Decrease of the D4 dopamine receptor messenger RNA expression in lymphocytes from patients with major depression

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Circulating dopamine level, in lung carcinoma patients, inhibits proliferation and cytotoxicity of CD4+ and CD8+ T cells by D1 dopamine receptors: an in vitro analysis

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Physiological concentrations of dopamine inhibit the proliferation and cytotoxicity of human CD4+ and CD8+ T cells in vitro: a receptor-mediated mechanism.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Altered neurotransmission in brains of autoimmune mice: pharmacological and neurochemical evidence

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

The immunoregulatory role of dopamine: an update

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Towards neuroimmunotherapy for cancer: the neurotransmitters glutamate, dopamine and GnRH-II augment substantially the ability of T cells of few head and neck cancer patients to perform spontaneous migration, chemotactic migration and migration towa

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Neurobehavioral aspects, pathophysiology, and management of Tourette syndrome

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Elevated intrasynaptic dopamine release in Tourette's syndrome measured by PET.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Anti-inflammatory role of sympathetic nerves in chronic intestinal inflammation.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Divergent effects of norepinephrine, dopamine and substance P on the activation, differentiation and effector functions of human cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Psychopathology in children and adolescents with Tourette's syndrome: a controlled study.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Inhibition of immune cell proliferation with haloperidol and relationship of tyrosine hydroxylase expression to immune cell growth.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Bromocriptine treatment of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Dopamine selectively induces migration and homing of naive CD8+ T cells via dopamine receptor D3.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Therapy with interferon-beta modulates endogenous catecholamines in lymphocytes of patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Reduced density of dopamine D2-like receptors on peripheral blood lymphocytes in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Phagocyte-derived catecholamines enhance acute inflammatory injury

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12476

21 January 2018

Identifiers

10.1111/APHA.12476

1 reference

Europe PubMed Central

2 September 2017

1 reference

Europe PubMed Central

2 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38366498&oldid=1756223392"